About this trial
The purpose of this study is to develop a multi-level PrEP adherence and persistence intervention as an adaptation of the TENDAI ('grateful' in Shona) program, a problem-solving approach to reduce depression and increase HIV treatment adherence among people living with HIV in Zimbabwe. The new intervention, TENDAI4PrEP, will be designed to improve PrEP uptake and persistence among pregnant persons in Zimbabwe. If feasibility, acceptability, and preliminary efficacy are demonstrated, the intervention will be ready for large-scale effectiveness/implementation testing. This program will has the potential to address a critical public health challenge impacting pregnant and postpartum persons in Zimbabwe: the prevention of HIV acquisition and transmission.
Eligibility criteria
Qualifiers
Pregnant
Presenting at the Chitungwiza Central Hospital ANC
Aged 15+
Willing to provide informed consent or assent
Disqualifiers
Inability to provide informed consent/assent and/or complete procedures in Shona or English
Current interfering untreated or unstable mental health condition that precludes functional involvement in the study (e.g., active psychosis, untreated bipolar disorder)
Trial design
Treatments tested in this trial
- TENDAI4PrEP
- Enhanced treatment as usual
Treatment groups
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
University of Zimbabwe
Collaborator
Boston University
Collaborator